Phio Pharmaceuticals Corp. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Phio Pharmaceuticals Corp. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Phio Pharmaceuticals Corp. Return On Equity for the quarter ending September 30, 2024 was -135 %, a 1.73% decline year-over-year.
  • Phio Pharmaceuticals Corp. annual Return On Equity for 2023 was -135 %, a 78.4% decline from 2022.
  • Phio Pharmaceuticals Corp. annual Return On Equity for 2022 was -75.5 %, a 52.6% decline from 2021.
  • Phio Pharmaceuticals Corp. annual Return On Equity for 2021 was -49.5 %, a 18.2% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -135 -59.2 -78.4% Jan 1, 2023 Dec 31, 2023
2022 -75.5 -26 -52.6% Jan 1, 2022 Dec 31, 2022
2021 -49.5 +11 +18.2% Jan 1, 2021 Dec 31, 2021
2020 -60.5 +42.2 +41.1% Jan 1, 2020 Dec 31, 2020
2019 -103 +51 +33.2% Jan 1, 2019 Dec 31, 2019
2018 -154 +103 +40% Jan 1, 2018 Dec 31, 2018
2017 -256 -117 -83.8% Jan 1, 2017 Dec 31, 2017
2016 -139 -24.5 -21.3% Jan 1, 2016 Dec 31, 2016
2015 -115 +58.9 +33.9% Jan 1, 2015 Dec 31, 2015
2014 -174 +138 +44.3% Jan 1, 2014 Dec 31, 2014
2013 -312 -663 -189% Jan 1, 2013 Dec 31, 2013
2012 351 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.